Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer.

Song L, Smith MA, Doshi P, Sasser K, Fulp W, Altiok S, Haura EB.

J Thorac Oncol. 2014 Jul;9(7):974-82. doi: 10.1097/JTO.0000000000000193.

PMID:
24922005
[PubMed - in process]
2.

Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non-Small Cell Lung Cancer.

Yoshida T, Zhang G, Smith MA, Lopez AS, Bai Y, Li J, Fang B, Koomen J, Rawal B, Fisher KJ, Chen AY, Kitano M, Morita Y, Yamaguchi H, Shibata K, Okabe T, Okamoto I, Nakagawa K, Haura EB.

Clin Cancer Res. 2014 Jun 11. [Epub ahead of print]

PMID:
24919575
[PubMed - as supplied by publisher]
3.

Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.

Kris MG, Johnson BE, Berry LD, Kwiatkowski DJ, Iafrate AJ, Wistuba II, Varella-Garcia M, Franklin WA, Aronson SL, Su PF, Shyr Y, Camidge DR, Sequist LV, Glisson BS, Khuri FR, Garon EB, Pao W, Rudin C, Schiller J, Haura EB, Socinski M, Shirai K, Chen H, Giaccone G, Ladanyi M, Kugler K, Minna JD, Bunn PA.

JAMA. 2014 May 21;311(19):1998-2006. doi: 10.1001/jama.2014.3741.

PMID:
24846037
[PubMed - indexed for MEDLINE]
4.

The ethical imperative of risk disclosure in research: the answer is always yes.

Quinn GP, Haura EB, Murphy D.

Am J Bioeth. 2014 Apr;14(4):18-9. doi: 10.1080/15265161.2014.889242. No abstract available.

PMID:
24730484
[PubMed - in process]
5.

TGF-β-inducible microRNA-183 silences tumor-associated natural killer cells.

Donatelli SS, Zhou JM, Gilvary DL, Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D, Wei S, Djeu JY.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4203-8. doi: 10.1073/pnas.1319269111. Epub 2014 Feb 28.

PMID:
24586048
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

SHP2E76K mutant promotes lung tumorigenesis in transgenic mice.

Schneeberger VE, Luetteke N, Ren Y, Berns H, Chen L, Foroutan P, Martinez GV, Haura EB, Chen J, Coppola D, Wu J.

Carcinogenesis. 2014 Feb 19. [Epub ahead of print]

PMID:
24480804
[PubMed - as supplied by publisher]
7.

Stakeholder perceptions of thoracic rapid tissue donation: An exploratory study.

McIntyre J, Pratt C, Pentz RD, Haura EB, Quinn GP; FORWARD.

Soc Sci Med. 2013 Dec;99:35-41. doi: 10.1016/j.socscimed.2013.08.035. Epub 2013 Sep 6.

PMID:
24355468
[PubMed - indexed for MEDLINE]
8.

Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer.

Chiappori A, Williams C, Northfelt DW, Adams JW, Malik S, Edelman MJ, Rosen P, Van Echo DA, Berger MS, Haura EB.

J Thorac Oncol. 2014 Jan;9(1):121-5. doi: 10.1097/JTO.0000000000000027.

PMID:
24346101
[PubMed - in process]
9.

GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells.

Remsing Rix LL, Kuenzi BM, Luo Y, Remily-Wood E, Kinose F, Wright G, Li J, Koomen JM, Haura EB, Lawrence HR, Rix U.

ACS Chem Biol. 2014 Feb 21;9(2):353-8. doi: 10.1021/cb400660a. Epub 2013 Nov 20.

PMID:
24215125
[PubMed - in process]
10.

Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.

Li J, Bennett K, Stukalov A, Fang B, Zhang G, Yoshida T, Okamoto I, Kim JY, Song L, Bai Y, Qian X, Rawal B, Schell M, Grebien F, Winter G, Rix U, Eschrich S, Colinge J, Koomen J, Superti-Furga G, Haura EB.

Mol Syst Biol. 2013 Nov 5;9:705. doi: 10.1038/msb.2013.61.

PMID:
24189400
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Signaling control by epidermal growth factor receptor and MET: rationale for cotargeting strategies in lung cancer.

Haura EB, Smith MA.

J Clin Oncol. 2013 Nov 10;31(32):4148-50. doi: 10.1200/JCO.2013.50.8234. Epub 2013 Oct 7. No abstract available.

PMID:
24101046
[PubMed - indexed for MEDLINE]
12.

Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma.

Creelan BC, Antonia S, Noyes D, Hunter TB, Simon GR, Bepler G, Williams CC, Tanvetyanon T, Haura EB, Schell MJ, Chiappori A.

J Immunother. 2013 Oct;36(8):442-50. doi: 10.1097/CJI.0b013e3182a80237.

PMID:
23994887
[PubMed - indexed for MEDLINE]
13.

Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer.

Kim JY, Beg AA, Haura EB.

Expert Opin Ther Targets. 2013 Oct;17(10):1109-12. doi: 10.1517/14728222.2013.833188. Epub 2013 Aug 28.

PMID:
23984985
[PubMed - indexed for MEDLINE]
14.

A miniaturized chemical proteomic approach for target profiling of clinical kinase inhibitors in tumor biopsies.

Chamrád I, Rix U, Stukalov A, Gridling M, Parapatics K, Müller AC, Altiok S, Colinge J, Superti-Furga G, Haura EB, Bennett KL.

J Proteome Res. 2013 Sep 6;12(9):4005-17. doi: 10.1021/pr400309p. Epub 2013 Aug 20.

PMID:
23901793
[PubMed - indexed for MEDLINE]
15.

TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer.

Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, Jonathan KA, Beg AA, Haura EB.

Carcinogenesis. 2013 Nov;34(11):2525-30. doi: 10.1093/carcin/bgt244. Epub 2013 Jul 9.

PMID:
23839018
[PubMed - indexed for MEDLINE]
16.

Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells.

Kim JY, Welsh EA, Oguz U, Fang B, Bai Y, Kinose F, Bronk C, Remsing Rix LL, Beg AA, Rix U, Eschrich SA, Koomen JM, Haura EB.

Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12414-9. doi: 10.1073/pnas.1220674110. Epub 2013 Jul 8.

PMID:
23836654
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The NAD+ synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribosomal RNA transcription.

Song T, Yang L, Kabra N, Chen L, Koomen J, Haura EB, Chen J.

J Biol Chem. 2013 Jul 19;288(29):20908-17. doi: 10.1074/jbc.M113.470302. Epub 2013 Jun 4.

PMID:
23737528
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

Hopewell EL, Zhao W, Fulp WJ, Bronk CC, Lopez AS, Massengill M, Antonia S, Celis E, Haura EB, Enkemann SA, Chen DT, Beg AA.

J Clin Invest. 2013 Jun 3;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.

PMID:
23635779
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Healthcare providers' knowledge and attitudes about rapid tissue donation (RTD): phase one of establishing a rapid tissue donation programme in thoracic oncology.

Schabath MB, McIntyre J, Pratt C, Gonzalez LE, Munoz-Antonia T, Haura EB, Quinn GP.

J Med Ethics. 2014 Feb;40(2):139-42. doi: 10.1136/medethics-2013-101340. Epub 2013 Apr 4.

PMID:
23557908
[PubMed - in process]
Free PMC Article
20.

Tripartite motif containing 28 (Trim28) can regulate cell proliferation by bridging HDAC1/E2F interactions.

Chen L, Chen DT, Kurtyka C, Rawal B, Fulp WJ, Haura EB, Cress WD.

J Biol Chem. 2012 Nov 23;287(48):40106-18. doi: 10.1074/jbc.M112.380865. Epub 2012 Oct 11.

PMID:
23060449
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk